VENLAFAXINE
- Product NDC
- 61919-351
- 11-digit product format
- 619190351
- Labeler code
- 61919
- Product ID
- 61919-351_92d922a0-5a18-9cf9-e053-2995a90a0cbd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VENLAFAXINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA202036
- Marketing category
- ANDA
- Marketing start
- 2017-10-31
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-351-60 | 61919035160 | 60 TABLET in 1 BOTTLE (61919-351-60) | 60 tablet | 2019-09-18 | 0000-00-00 | No | No | Current |